Methotrexate Treatment for Ectopic Pregnancy

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Ectopic Pregnancy
Interventions
PROCEDURE

Single-dose Methotrexate

"Participants in the single-dose protocol group received intramuscular methotrexate at single dose of 50 mg/m2 on day 0 (the initial day of treatment). The β-hCG levels were then measured on day 4 and 7. If there was at least 15% β-hCG drop between day 4 and 7, the treatment was deemed successful and the participants were then followed with weekly β-hCG measurements until the results was negative. If a 15% drop on day 4 and 7 did not occur, a second dose was administrated on day 7 and β-hCG levels were then measured on day 11 and 14. Participants were referred for surgical treatment if β-hCG levels fell \<15% between day 11 and 14."

PROCEDURE

Two-dose methotrexate protocol

"Participants in the two-dose protocol group received intramuscular methotrexate twice at dose of 50 mg/m2 on day 0 and 4. A third dose of methotrexate was given on day 7 if β-hCG levels did not fall 15% between day 4 and 7 after two-dosing. A fourth dose was administered on day 11 if β-hCG levels fell \<15% between day 7 and 11. Then, a final β-hCG level was checked on day 14. If a 15% drop was not seen, the medical treatment was deemed refractory and the patients were referred for surgical treatment."

Trial Locations (1)

Unknown

CHA Gangnam Medical Center, Seoul

All Listed Sponsors
lead

CHA University

OTHER

NCT01855568 - Methotrexate Treatment for Ectopic Pregnancy | Biotech Hunter | Biotech Hunter